Application Note

Extractables In Single-Use Systems Used In ADC Manufacturing

Source: Cytiva
Antibody drug conjugates ADCs GettyImages-1715913285

Single-use (SU) systems show significant promise for antibody-drug conjugate (ADC) manufacturing. However, the use of organic solvents in the ADC process raises concerns about potential leachables from the plastic and elastomeric materials in SU components. To address these questions, extractables studies were conducted on a disposable chromatography column housing as well as two different disposable flow paths. These studies utilized two solvents commonly employed in the ADC cytotoxin conjugation step: DMA and DMSO.

The study conditions were intentionally designed to be more extreme than typical ADC manufacturing processes. Extractable organic compounds and trace elements from the SU components were identified and semi-quantified using a range of analytical techniques. The low levels of extractables detected in this study support the use of ReadyToProcess™ columns, ÄKTA readyflux™ flow kits, and ÄKTA ready™ flow kits in ADC manufacturing processes.

access the Application Note!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Discovery Online